The global Intelligent Drug Discovery Market is forecasted to be worth USD 3,711.8 Million by 2027, according to a current analysis by Emergen Research. The intelligent drug technology market is growing, and several pharmaceutical companies are focusing on the development of drugs using artificial intelligence. The pharma companies are taking advantage of the technology to discover drugs for more complex diseases.
The artificial intelligence (AI) in drug discovery market consists of sales of AI software used in drug discovery and related services. Artificial Intelligence for drug discovery is a technology that uses a simulation of human intelligence process by machines to tackle complex problems in drug discovery. It helps to find new molecules to identify drug targets and develop personalized medicines in the pharmaceutical industry. The market includes software licenses required for AI in drug discovery.
The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research.
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market” is likely to grow at a CAGR of around 23.6% during the forecast period, i.e.
Data Bridge Market Research analyzes that the global Artificial Intelligence (AI) in drug discovery market is expected to reach the value of USD 24,618.25 million by 2029, at a CAGR of 53.3% during the forecast period.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics...... @ @ https://bit.ly/3D4dtix
The global artificial intelligence (AI) in drug discovery market size is expected to grow from $791.8 million in 2021 to $2,994.5 million in 2026 at a rate of 30.5%.
TBRC global artificial intelligence (AI) in drug discovery market report includes metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases
TBRC global artificial intelligence (AI) in drug discovery market report includes metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases https://bit.ly/3tG69qM
The global drug discovery informatics market size is expected to reach USD 5.62 billion by 2028 according to a new study by Polaris Market Research. The report “Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow (Discovery Informatics, Development Informatics); By Mode (Outsourced, In-house); By Services (Sequence Analysis Platforms, Molecular Modeling, Docking, Clinical Trial Data Management, Others); By Regions; Segment Forecast, 2021 – 2028”
The Business Research Company added a report “Artificial Intelligence (AI) In Drug Discovery Market” to its collection – which covers the industry overview with size, share, development, demand and distribution. https://bit.ly/2EcMAyX
The rna targeting small molecule drug discovery market size is expected to see exponential growth in the next few years. It will grow to $3.97 billion in 2028 at a compound annual growth rate (CAGR) of 22.2%.
Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. See Full Report @ http://bit.ly/1zB1l1W
Prescription drugs play a vital role in modern healthcare, offering effective treatments for a wide range of medical conditions. The prescribed drug market, encompassing the development, manufacturing, distribution, and sale of these medications, is a crucial sector within the healthcare industry. This blog delves into the prescribed drug market in 2024, exploring its size, segmentation, key trends, and future outlook.
A newly published report by Market Statsville Group (MSG), title Global Drug Discovery Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Drug Discovery market will showcase an impressive CAGR from 2024 to 2033.
The AI in Healthcare Market size is projected to grow from USD 14.6 Billion in 2023 to USD 102.7 Billion by 2028; it is expected to grow at a CAGR of 47.6% during the forecast period.
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision), Application, End User and Region - Global Forecast to 2028
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision), Application, End User and Region - Global Forecast to 2028
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision), Application, End User and Region - Global Forecast to 2028
According to the Market Statsville Group (MSG), the global AI in drug discovery market size is expected to grow from USD 910.7 million in 2021 to USD 9,072.2 million by 2030, at a CAGR of 29.1% from 2022 to 2030.
The Artificial Intelligence In Healthcare Market Report provides a comprehensive analysis of the global Artificial Intelligence In Healthcare market, highlighting key trends, drivers, challenges, and opportunities shaping the industry.
According to the Market Statsville Group (MSG), the global AI in drug discovery market size is expected to grow from USD 910.7 million in 2021 to USD 9,072.2 million by 2030, at a CAGR of 29.1% from 2022 to 2030. A machine that uses contemporary technology to carry out tasks that are similar to those carried out by the human mind is referred to as having artificial intelligence (AI). Finding drugs that can help prevent or treat particular diseases is the main goal of drug discovery research. The need for artificial intelligence (AI) in the drug discovery industry was fuelled by the challenges of assessing, acquiring and using data to tackle challenging medical problems.
A new study titled “Drug Discovery Services Market Size 2022”, published by Market Statsville Group (MSG), provides information on regional and global markets. MSG expects the global Drug Discovery Services market will showcase an impressive CAGR from 2022 to 2030.
This report studies the global Healthcare Artificial Intelligence market, analyzes and researches the Healthcare Artificial Intelligence development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like IBM Watson Health AiCure Atomwise Cyrcadia Health Lifegraph
The "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Optical Imaging market along with the estimates and forecasts of the revenue and market share analysis.
Global CRO Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global CRO market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Detailed report at: http://www.reportsandintelligence.com/global-cro-2015-2019-market
The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global “veterinary drugs market”, finds Fortune Business Insights in their new study
The increasing demand for new drugs, the rising number of new diseases and increasing collaborations among various firms is expected to drive the market in the forecast period.
Biosimulation is a technique in which computer programs are used for the simulation of biological processes. Biosimulation has wide reaching applications in the field of drug discovery and development of new drugs. It is a tool used for prediction and biosimulation is used to predict the future outcomes of current experiments related to discovery and development of new drugs.
Technological advancements in diabetic ketoacidosis treatment, significant prevalence of target diseases, and rising private & government funding for new drug discovery are expected to be some major drivers for the market.
Market Research Future (MRFR) has published a report stating that the global cell viability market is marked to expand at a CAGR of 9.2% during the forecast period of 2018-2023
Global Oncology Drugs Market is a rapidly growing market, driven by technological advancements, changing consumer preferences, and regulatory policies. The market is highly competitive and is segmented by product type, application, and geography
Market segmentation and targeted marketing strategies are essential for effectively reaching diverse customer segments and addressing specific market needs in the Metal-Organic Frameworks (MOFs) industry. Understanding customer preferences, industry trends, and competitive landscapes enables companies to tailor their marketing efforts and maximize market penetration.
According to the Market Statsville Group (MSG), the Global Drug Phenotypic Screening Platform Market size is expected to grow at a CAGR of 14.3% from 2023 to 2033.
The Biosimulation Market Report provides a comprehensive analysis of the global Biosimulation market, highlighting key trends, drivers, challenges, and opportunities shaping the industry.
The report also includes an in-depth analysis of the competitive landscape and regional scope of the Lung Cancer Screening Market. Additionally, the report will be updated in line with changes in market dynamics and economic scenarios due to the COVID-19 pandemic.